Lifeist Announces Closing of Non-Brokered Debt Financing
2023年5月20日 - 6:00AM
Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV:
LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF),
a health-tech company that leverages advancements in science and
technology to build breakthrough companies that transform human
wellness, today announced that it has closed a tranche of the
non-brokered private placement (the "Offering") of secured
convertible debentures (the "Debentures") originally announced on
March 16, 2023 for aggregate gross proceeds to the Company of
$167,125 (the “Funded Amount”). The Company intends to use the
proceeds from the Offering to help fuel expansion of Lifeist’s
cannabis and nutraceuticals businesses, CannMart, Inc (“CannMart”)
and Mikra Cellular Sciences Inc. (“Mikra”).
The Debentures sold in the Offering carry a principal amount of
$208,906 including an original issuance discount (“Principal
Amount”), will not bear interest, and mature on May 18, 2024 (the
“Maturity Date”). Holders of the Debentures will be entitled to
convert the Funded Amount of the Debentures at any time on or prior
to the Maturity Date at a deemed price of $0.05 per unit,
consisting of one common share and one warrant, with each warrant
exercisable by the holder to acquire one additional share at
$0.05625 per share until May 18, 2026, subject to standard
adjustments. The repayment of the Principal Amount of the
Debentures will be secured by a security agreement over specific
equipment of the Company. This Offering is part of an offering by
the Company of Debentures to raise up to a maximum of $800,000, to
be completed in one or more tranches as the Company may determine.
Completion of the Offering is subject to certain conditions
including, but not limited to, the receipt of all necessary
approvals. There can be no assurance that the Offering will be
completed, whether in whole or in part.
There are no finders fees associated with the Offering. Closing
of the Offering is subject to regulatory approval, including that
of the TSX Venture Exchange ("TSXV").
The Debentures were offered and sold by private placement in
Canada pursuant to exemptions from the prospectus requirements
under National Instrument 45-106 - Prospectus Exemptions.
This news release does not constitute an offer to sell or a
solicitation of an offer to sell any of the securities in the
United States. The securities have not been and will not be
registered under the U.S. Securities Act of 1933 (the “U.S.
Securities Act”) or any state securities laws and may not be
offered or sold within the United States or to U.S. Persons (as
defined in Regulation S under the U.S. Securities Act) unless
registered under the U.S. Securities Act and applicable state
securities laws or an exemption from such registration is
available.
About Lifeist Wellness Inc.
Sitting at the forefront of the post-pandemic wellness
revolution, Lifeist leverages advancements in science and
technology to build breakthrough companies that transform human
wellness. Portfolio business units include: CannMart, which
operates a B2B wholesale distribution business facilitating
recreational cannabis sales to Canadian provincial government
control boards including for CannMart Labs, a BHO extraction
facility producing high margin cannabis 2.0 products; Australian
Vaporizers, one of Australia’s largest online retailers of
vaporizers and accessories; and Mikra, a biosciences and consumer
wellness company developing and selling innovative therapies for
cellular health.
Information on Lifeist and its businesses can be
accessed through the links
below:www.lifeist.comhttps://cannmart.comhttps://www.roilty.cohttps://wearemikra.com/www.australianvaporizers.com.au
Contacts
Meni Morim, Lifeist Wellness Inc., CEOPh: 647-362-0390Email:
ir@lifeist.com
Neither the TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of this release or has in any way approved
or disapproved of the contents of this press release.
Forward Looking Information
This news release contains “forward-looking
information” within the meaning of applicable securities laws. All
statements contained herein that are not historical in nature
contain forward-looking information. Forward-looking information
can be identified by words or phrases such as “may”, “expect”,
“likely”, “should”, “would”, “plan”, “anticipate”, “intend”,
“potential”, “proposed”, “estimate”, “believe” or the negative of
these terms, or other similar words, expressions and grammatical
variations thereof, or statements that certain events or conditions
“may” or “will” happen.
The forward-looking information contained
herein, including, without limitation, statements related to the
anticipated timing of the closing of the Offering, the anticipated
use of proceeds from the Offering, and the receipt of required
approvals, are made as of the date of this news release and is
based on assumptions management believed to be reasonable at the
time such statements were made, including, without limitation,
expectations that: the Company will have the ability to complete
the Offering and/or utilize the proceeds on the terms and within
the timelines anticipated; and the Company’s ability to obtain the
required approvals to complete the Offering on the proposed terms
and timeline. While we consider these assumptions to be reasonable
based on information currently available to management, there is no
assurance that such expectations will prove to be correct. By its
nature, forward-looking information is subject to inherent risks
and uncertainties that may be general or specific and which give
rise to the possibility that expectations, forecasts, predictions,
projections or conclusions will not prove to be accurate, that
assumptions may not be correct and that objectives, strategic goals
and priorities will not be achieved. A variety of factors,
including known and unknown risks, many of which are beyond our
control, could cause actual results to differ materially from the
forward-looking information in this press release. Such factors
include, without limitation: the Company’s inability to complete
the Offering and/or utilize the proceeds on the terms and within
the timelines anticipated or at all; and the Company’s inability to
obtain the required approvals to complete the Offering on the
proposed terms or timeline or at all, and risks relating to the
Company’s ability to execute its business strategy and the benefits
realizable therefrom. Additional risk factors can also be found in
the Company’s current MD&A which has been filed under the
Company’s SEDAR profile at www.sedar.com. Readers are cautioned not
to put undue reliance on forward-looking information. The Company
undertakes no obligation to update or revise any forward-looking
information, whether as a result of new information, future events
or otherwise, except as required by applicable law. Forward-looking
statements contained in this news release are expressly qualified
by this cautionary statement.
Source: Lifeist Wellness Inc.
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 4 2024 まで 5 2024
Lifeist Wellness (TSXV:LFST)
過去 株価チャート
から 5 2023 まで 5 2024